IP Library Granted Patent US 7,062,317
Granted Patent B2
US 7,062,317 · App. 10/460,484 · Granted Jun 13, 2006

Monopolar and bipolar current application for transdermal drug delivery and analyte extraction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,062,317
App. No.
10/460,484
Granted
Jun 13, 2006
Kind
B2
Abstract

A device for facilitating transdermal passage of a substance through skin on the body of a subject is provided. The device preferably includes afcn electrode and a control unit. In a preferred embodiment, the control unit is adapted to drive the electrode to apply to the skin a current capable of ablating stratum corneum epidermidis of the skin, so as to facilitate transdermal passage of the substance. The control unit detects generation of at least one spark responsive to application of the current, and modifies a parameter of the current responsive to detecting the generation of the at least one spark.

Claims (46)

1. A device for facilitating passage of a substance through skin on the body of a subject, comprising:

an electrode, adapted to be applied to the skin;

a mechanical sensor, adapted to detect an indication of a contact force between the electrode and the skin and to generate a sensor signal responsive thereto; and

a control unit, adapted to receive the sensor signal and, responsive thereto, to drive the electrode to apply a current to the skin capable of ablating stratum corneum epidermidis thereof, so as to facilitate transdermal passage of the substance.

2. A device according to claim 1 , wherein the electrode comprises a first portion having a first cross-section, and a second portion having a second cross-section which is different from the first cross-section, the electrode being adapted to be placed such that the first portion is in contact with the skin.

3. A device according to claim 2 , wherein the second cross-section has a characteristic diameter larger than a characteristic diameter of the first cross-section.

4. A device according to claim 2 , wherein the first portion is adapted for insertion into the skin responsive to ablation of the stratum corneum.

5. A device according to claim 1 , wherein the electrode comprises the substance, and wherein the control unit is adapted to drive the electrode to apply to the skin the current capable of ablating stratum corneum epidermidis of the skin, so as to facilitate delivery of the substance from the electrode through the skin.

6. A device according to claim 1 , comprising a housing, wherein the electrode comprises:

an ablating electrode, fixed to the housing and adapted to apply the current to the skin capable of ablating stratum corneum epidermidis in a vicinity of the ablating electrode, so as to facilitate the transdermal passage of the substance; and

a non-ablating electrode, fixed to the housing and adapted to provide a return path for the current, substantially without ablating stratum corneum in a vicinity of the non-ablating electrode.

7. A device according to claim 6 , wherein the ablating electrode comprises at least 100 ablating electrodes.

8. A device according to claim 6 , wherein the non-ablating electrode comprises at least 3 non-ablating electrodes.

9. A device according to claim 6 , wherein the non-ablating electrode comprises two non-ablating electrodes, and wherein the control unit is adapted to measure electrical impedance between the two non-ablating electrodes.

10. A device for facilitating passage of a substance through skin on the body of a subject, comprising:

an electrode, a first portion of which having a first cross-section, and a second portion of which having a second cross-section which is different from the first cross-section and such as to inhibit insertion of the second portion into the skin, the electrode being adapted to be placed such that the first portion is in contact with the skin; and

a control unit, adapted to drive the electrode to apply an electric current to the skin capable of ablating stratum corneum epidermidis thereof, so as to facilitate passage through the skin of the substance.

11. A device for facilitating passage of a substance through skin on the body of a subject, comprising:

an electrode, a first portion of which having a first cross-section, and a second portion of which having a second cross-section which is different from the first cross-section, the electrode being adapted to be placed such that the first portion is in contact with the skin; and

a control unit, adapted to:

drive the electrode to apply an electric current to the skin capable of ablating stratum corneum epidermidis thereof, so as to facilitate passage through the skin of the substance, and

detect contact of the second portion and the skin, and terminate the current responsive thereto, so as to inhibit insertion of the second portion into the skin.

12. A device for facilitating passage of a substance through skin on the body of a subject, comprising:

an electrode, a first portion of which having a first cross-section, and a second portion of which having a second cross-section which is different from the first cross-section, the electrode being adapted to be placed such that the first portion is in contact with the skin; and

a control unit, adapted to:

drive the electrode to apply an electric current to the skin capable of ablating stratum corneum epidermidis thereof, so as to facilitate passage through the skin of the substance, and

detect one or more sparks generated responsive to the current.

13. A device for facilitating passage of a substance through skin on the body of a subject, comprising:

a longitudinal electrode, comprising:

a first portion, having a first geometrical property at a first longitudinal site of the electrode, and

a second portion, having a second geometrical property at a second longitudinal site of the electrode, the second geometrical property being different from the first geometrical property, and the second portion being substantially non-conductive, the electrode being adapted to be placed such that the first portion is in contact with the skin; and

a control unit, adapted to drive the electrode to apply an electric current to the skin capable of ablating stratum corneum epidermidis thereof.

14. A device for facilitating passage of a substance through skin on the body of a subject, comprising:

a longitudinal electrode, comprising:

a first portion, having a first geometrical property at a first longitudinal site of the electrode, and

a second portion, having a second geometrical property at a second longitudinal site of the electrode, the second geometrical property being different from the first geometrical property, the electrode being adapted to be placed such that the first portion is in contact with the skin; and

a control unit, adapted to:

drive the electrode to apply an electric current to the skin capable of ablating stratum corneum epidermidis thereof, and

detect contact of the second portion and the skin, and to terminate the current responsive thereto, so as to inhibit insertion of the second portion into the skin.

15. A device for facilitating passage of a substance through skin on the body of a subject, comprising:

a longitudinal electrode, comprising:

a first portion, having a first geometrical property at a first longitudinal site of the electrode, and

a second portion, having a second geometrical property at a second longitudinal site of the electrode, the second geometrical property being different from the first geometrical property, the electrode being adapted to be placed such that the first portion is in contact with the skin; and

a control unit, adapted to:

drive the electrode to apply an electric current to the skin capable of ablating stratum corneum epidermidis thereof, and

detect one or more sparks generated responsive to the current.

Assignments (5)
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2012
From: TRANSPHARMA MEDICAL LTD
To: SYNERON MEDICAL LTD
Reel/Frame 028256/0375 →
CHANGE OF NAME Recorded May 23, 2012
From: TRANSPHARMA LTD
To: TRANSPHARMA MEDICAL LTD
Reel/Frame 028256/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2012
From: AVRAHAMI, ZOHAR; SOHN, ZE'EV
To: TRANSPHARMA LTD
Reel/Frame 028144/0466 →